An israeli company have claimed that they will have cure for cancer by 2020, at a much lower cost with no or minimal side-effects.

‘There are varied types of treatment available for cancer that come with loads of side-effects and economic burden to the patients. This innovative invention proves promising and hopeful.’

According to the company’s director Dr. Ilan Morad, they looked for reasons why cancer drugs and treatments are not working and found an effective way to counter it. Many drugs that treat cancer attack the carcinogenic cell at a specific target. But, MuTaTo (multi-target toxin), the so-called newly developed treatment, attacks the cancer cells’ receptors from three diverse directions. 




“Instead of attacking receptors one at a time, we attack receptors three at a time. Not even cancer can mutate three receptors at one time," said Morad. The treatment has undergone mice trial, and the company is further planning to try the medicines on humans through this year. After this, the medication will hit the market the next year, added Moran.
When 14.1 million new cases and 8.8 million deaths are being reported due to cancer every year, the Israeli biotech company’s cancer cure discovery has offered some positive hope.
Source-Medindia